Docebo Analyst Price Targets

Wall Street analyst price targets and consensus rating for Docebo (DCBO).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

7Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$39Upside to Avg. PT+30.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 2, 2026	Oppenheimer	Ken Wong	PT Raise	Outperform	$25→$35
Jul 17, 2026	Needham	Ryan MacDonald	Maintained	Buy	$31
Apr 22, 2026	Cantor Fitzgerald	Matthew Vanvliet	Maintained	Overweight	$28
Apr 22, 2026	Needham	Ryan MacDonald	Maintained	Buy	$31
Mar 2, 2026	Scotiabank	Kevin Krishnaratne	PT Cut	Sector Outperform	$32→$25
Mar 2, 2026	Morgan Stanley	Josh Baer	PT Cut	Equal-Weight	$28→$26
Feb 27, 2026	Needham	Ryan MacDonald	PT Cut	Buy	$38→$31
Jan 30, 2026	Scotiabank	Kevin Krishnaratne	PT Cut	Sector Outperform	$35→$32
Jan 29, 2026	Needham	Ryan MacDonald	Maintained	Buy	$38
Jan 21, 2026	Cantor Fitzgerald	Matthew Vanvliet	PT Cut	Overweight	$35→$28
Dec 24, 2025	Cantor Fitzgerald	Matt VanVliet	Assumes	Overweight	$35
Nov 10, 2025	Morgan Stanley	Josh Baer	PT Cut	Equal-Weight	$34→$28
Nov 7, 2025	Needham	Ryan MacDonald	PT Cut	Buy	$42→$38
Nov 5, 2025	Oppenheimer	Ken Wong	Initiate	Outperform	$35
Oct 29, 2025	CIBC	Stephanie Price	PT Cut	Outperformer	$37→$36
Oct 3, 2025	TD Cowen	Daniel Chan	Reinstates	Buy	$37
Oct 3, 2025	TD Securities	Daniel Chan	Reinstates	Buy	$37
Jun 9, 2025	Cantor Fitzgerald	Yi Fu Lee	Initiate	Overweight	$35
May 12, 2025	Scotiabank	Kevin Krishnaratne	PT Cut	Sector Outperform	$45→$40
May 12, 2025	Morgan Stanley	Josh Baer	Downgrade	Overweight→Equal-Weight	$41→$32

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on Docebo, Raises Price Target to $35

Oppenheimer analyst Ken Wong maintains Docebo (NASDAQ:DCBO) with a Outperform and raises the price target from $25 to $35.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Docebo, Maintains $31 Price Target

Needham analyst Ryan MacDonald reiterates Docebo (NASDAQ:DCBO) with a Buy and maintains $31 price target.

Benzinga Newsdesk

PRO
Watching Docebo; Shares See Volume To The Upside, Hearing Zacks HomeRun Investor Newsletter Mentions Stock As A Buy

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Docebo, Maintains $28 Price Target

Cantor Fitzgerald analyst Matthew Vanvliet reiterates Docebo (NASDAQ:DCBO) with a Overweight and maintains $28 price target.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Docebo, Maintains $31 Price Target

Needham analyst Ryan MacDonald reiterates Docebo (NASDAQ:DCBO) with a Buy and maintains $31 price target.

Benzinga Newsdesk

PRO
Scotiabank Maintains Sector Outperform on Docebo, Lowers Price Target to $25

Scotiabank analyst Kevin Krishnaratne maintains Docebo (NASDAQ:DCBO) with a Sector Outperform and lowers the price target from $32 to $25.

Benzinga Newsdesk

Docebo Inc

Docebo Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on Docebo, Raises Price Target to $35

PRO
Needham Reiterates Buy on Docebo, Maintains $31 Price Target

PRO
Watching Docebo; Shares See Volume To The Upside, Hearing Zacks HomeRun Investor Newsletter Mentions Stock As A Buy

PRO
Cantor Fitzgerald Reiterates Overweight on Docebo, Maintains $28 Price Target

PRO
Needham Reiterates Buy on Docebo, Maintains $31 Price Target

PRO
Scotiabank Maintains Sector Outperform on Docebo, Lowers Price Target to $25

People Also Watch

People Also Watch

Docebo Inc

Docebo Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROOppenheimer Maintains Outperform on Docebo, Raises Price Target to $35

PRONeedham Reiterates Buy on Docebo, Maintains $31 Price Target

PROWatching Docebo; Shares See Volume To The Upside, Hearing Zacks HomeRun Investor Newsletter Mentions Stock As A Buy

PROCantor Fitzgerald Reiterates Overweight on Docebo, Maintains $28 Price Target

PRONeedham Reiterates Buy on Docebo, Maintains $31 Price Target

PROScotiabank Maintains Sector Outperform on Docebo, Lowers Price Target to $25

People Also Watch

People Also Watch

PRO
Oppenheimer Maintains Outperform on Docebo, Raises Price Target to $35

PRO
Needham Reiterates Buy on Docebo, Maintains $31 Price Target

PRO
Watching Docebo; Shares See Volume To The Upside, Hearing Zacks HomeRun Investor Newsletter Mentions Stock As A Buy

PRO
Cantor Fitzgerald Reiterates Overweight on Docebo, Maintains $28 Price Target

PRO
Needham Reiterates Buy on Docebo, Maintains $31 Price Target

PRO
Scotiabank Maintains Sector Outperform on Docebo, Lowers Price Target to $25